The legal scrutiny centers on whether Celsius and its leadership violated the Texas Deceptive Trade Practices Act. State regulators are specifically examining the company's subsidiary, Alani Nutrition, and its Alani Nu product line, questioning whether marketing tactics effectively targeted children and teenagers with high-caffeine beverages.

Investors felt the immediate impact of these allegations on June 4, 2026, when Celsius shares dropped 7.53%, closing at $27.75 per share. Pomerantz LLP, a firm with a long-standing history in securities class action litigation, is now seeking information from shareholders to determine if the company’s business practices warrant further legal action. Those holding equity in the firm are being directed to contact Danielle Peyton to discuss their potential involvement in the ongoing investigation.